Skip to main content
新芝生物 logo

新芝生物 — Investor Relations & Filings

Ticker · 920685 Beijing Stock Exchange Manufacturing
Open in API
Filings indexed 390 across all filing types
Latest filing 2024-07-30 Regulatory Filings
Country CN China
Listing Beijing Stock Exchange 920685

About 新芝生物

https://www.scientz.com/

Scientz Biotechnology specializes in the design and manufacture of high-performance life science instruments and laboratory equipment. The product range features ultrasonic cell disruptors, freeze dryers, gene guns, and high-pressure homogenizers, which are essential for sample preparation, cell lysis, and genetic engineering. The company also provides specialized solutions for tissue grinding, ultrasonic cleaning, and precise temperature control. These instruments serve a broad spectrum of applications in molecular biology, pharmaceutical research, environmental science, and agricultural technology. By integrating advanced ultrasonic and cryogenic technologies, Scientz supports research institutions and industrial laboratories in achieving accurate and reproducible results across various scientific disciplines.

Recent filings

Filing Released Lang Actions
第八届监事会第十一次会议决议公告
Regulatory Filings Classification · 95% confidence The document is a resolution announcement from the Supervisory Board (监事会) of Ningbo NewGen Bio-Tech Co., Ltd. It details the meeting date, attendance, agenda, and voting results on a proposal regarding the use of idle raised funds for cash management. The document is short (963 characters) and focuses on the meeting resolution and voting outcome rather than presenting financial statements or detailed reports. It is not an annual or interim report, audit report, or earnings release. It is also not a proxy solicitation or AGM information. The document fits best as a Regulatory Filing (RNS) because it is a formal announcement of a board meeting resolution and related disclosures that do not fit other specific categories.
2024-07-30 Chinese
关于召开 2024年第一次临时股东大会通知公告（提供网络投票）
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a notice announcing the convening of the 2024 first extraordinary general meeting of shareholders (临时股东大会通知公告). It details the meeting date, voting methods (onsite and online), eligibility, agenda items, registration methods, and contact information. It does not contain any financial statements, results, or detailed reports but serves as an official announcement to shareholders about the meeting and voting procedures. The document length is 2349 characters, which is relatively short and consistent with an announcement rather than a full report. Therefore, it fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA) or possibly Proxy Solicitation & Information Statement (PSI). However, since it is a notice of the meeting itself and voting arrangements rather than solicitation materials or voting results, the best fit is Declaration of Voting Results & Voting Rights Announcements (DVA) as it relates to shareholder voting rights and meeting notices. Confidence is high given the clear meeting notice nature and voting instructions.
2024-07-30 Chinese
第八届董事会第十二次会议决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement of resolutions passed at the 12th meeting of the 8th Board of Directors of Ningbo New Zhisheng Biotechnology Co., Ltd. It details the meeting date, attendance, agenda items, voting results, and references to related disclosures on the stock exchange platform. The content focuses on board meeting decisions, including approval of internal policies and proposals for shareholder meetings. There is no financial data, earnings information, or audit content. The document is not a full report but an official announcement of board meeting resolutions, which fits the category of Board/Management Information (MANG). The document length is short (1741 characters), and it is not a report publication announcement or regulatory filing. Therefore, the best classification is MANG with high confidence.
2024-07-30 Chinese
舆情管理制度
Governance Information Classification · 95% confidence The document is titled as a management system for public opinion (舆情管理制度) issued by the company's board. It details internal policies, organizational structure, responsibilities, and procedures for managing media and public opinion crises. There is no financial data, no mention of financial results, no voting results, no executive changes, no legal proceedings, no capital changes, and no report publication announcements. The document is a governance-related internal policy document approved by the board. Therefore, it fits best under Governance Information (CGR). The document length is 3507 characters, which is relatively short but contains substantive governance content, not just an announcement or notice.
2024-07-30 Chinese
第八届董事会第十一次会议决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement of the resolutions passed at the 11th meeting of the 8th Board of Directors of Ningbo New Zhi Biotechnology Co., Ltd. It details the meeting's attendance, the approval of a credit application proposal, voting results, and authorization for management to proceed with related legal and financial procedures. The content focuses on board decisions and management authorizations rather than financial results, audit opinions, or shareholder voting outcomes. It is not a full annual or interim report, nor is it a shareholder meeting announcement or voting result declaration. The document fits the category of Board/Management Information (MANG) as it reports on board meeting resolutions and management authorizations.
2024-07-23 Chinese
关于公司及子公司向具体相关银行申请授信的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement from Ningbo New Gen Bio-Tech Co., Ltd. regarding the company's and its subsidiaries' application for credit facilities from specific banks. It details the credit amounts, terms, and the board's approval of the credit application. The document is short (1201 characters) and focuses on financing activities, specifically credit/loan applications and related board resolutions. There is no financial statement or detailed financial report included. This fits the category of Capital/Financing Update (CAP), which covers updates on company fundraising, financing activities, or capital structure changes.
2024-07-23 Chinese

Browse filings by year

5 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.